Stroke Recovery Thinking Trial for Recent Stroke Patients
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests an under-the-tongue tablet (edaravone dexborneol) to help thinking and memory problems that can happen after an ischemic stroke. It may help people who recently had a stroke and now have trouble with attention, memory, or planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You had an ischemic stroke (blocked blood vessel) within the last 7 days.
- You have some trouble with memory, thinking, or attention after your stroke.
- You did not have serious memory or thinking problems before your stroke.
- You can read, write, and follow instructions for thinking tests.
- You do not have severe disability from your stroke (e.g., cannot move one side or speak clearly).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new sublingual tablet (Edaravone Dexborneol) to help people recover after a small stroke caused by disease of the small blood vessels in the brain. It aims to see if the drug can improve thinking and daily function.
This trial tests a medicine called edaravone dexborneol to see if it helps people recover from a recent ischemic stroke (a stroke caused by a blocked blood vessel). The medicine is given within 48 hours of the stroke, and the study will compare how well it works and if it is safe.
This trial tests a medication called edaravone dexborneol that is given under the tongue while you are being transferred to a hospital for a procedure to remove a blood clot from your brain. It is hoped that this medication can help protect your brain during the journey and improve recovery after the stroke.
This trial is testing whether a medicine called edaravone can help people who recently had a mild or moderate stroke caused by a blocked blood vessel in the brain. It aims to see if the drug improves recovery when given within the first two days after stroke symptoms start.
This study tests if a medicine called edaravone dexborneol, given within 48 hours of a stroke, can lower the risk of developing epilepsy later. It is for people who have had a stroke and are at high risk for post-stroke seizures.
This trial tests whether tiny particles from stem cells can help people recover thinking and memory after a recent stroke. Doctors will check if the treatment is safe and if it boosts brain function.
Hear when a new Post-Stroke Cognitive Impairment (PSCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.